Anne van Herwijnen

Anne van Herwijnen

I know how important knowledge of hereditary predisposition to cancer can be. This is why I think it is so important that comprehensive patient reports include precisely that carrier information, if the patient wishes to be informed of it.

Back to news

More news

Oncoanalyser 3.0 for cancer genomics is out, now supporting Illumina, Ultima Genomics & Roche platforms

Oncoanalyser 3.0 for cancer genomics is out, now supporting Illumina, Ultima Genomics & Roche platforms

04-09-2026

Extensive work on the underlying WiGiTS tools now enable users to analyze sequencing data from three sequencing platforms (Illumina, Ultima …

Collaboration for future-proof diagnostics and to accelerate research  

Collaboration for future-proof diagnostics and to accelerate research  

02-05-2023

Complete analysis of the DNA of children with cancer offers many possibilities. It maps out all possible targeted treatment options …

22 impactful scientific publications in  2022 

22 impactful scientific publications in 2022 

09-01-2023

In 2022, research groups from all over the world published 22 scientific papers in which data from the Hartwig Medical …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl